Bruker BioSciences to buy Bruker Optics
Bruker BioSciences has agreed to buy Bruker Optics, which specializes in molecular spectroscopy, for $135 million in cash and stock. Both companies are majority-owned by five members of the Laukien family. In a release, Bruker stated that "the combined company will have a broad range of mass spectrometry, X-ray analysis and molecular spectroscopy technology platforms to provide a unique combination of complementary systems for chemical and materials analysis, as well as for proteomics." During the past year Bruker Optics had about $78 million in revenue.
- see the release on the buyout for more
Comments